RECURRENT ASTROCYTOMA, IDH-MUTANT, GRADE 4
Clinical trials for RECURRENT ASTROCYTOMA, IDH-MUTANT, GRADE 4 explained in plain language.
Never miss a new study
Get alerted when new RECURRENT ASTROCYTOMA, IDH-MUTANT, GRADE 4 trials appear
Sign up with your email to follow new studies for RECURRENT ASTROCYTOMA, IDH-MUTANT, GRADE 4, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New brain cancer combo seeks safe dose in early trial
Disease control Recruiting nowThis early-stage trial is testing the safety and best dose of an experimental drug called triapine when given with radiation therapy. It's for adults whose glioblastoma or astrocytoma brain tumors have returned after previous treatment. The main goal is to find out if the combina…
Matched conditions: RECURRENT ASTROCYTOMA, IDH-MUTANT, GRADE 4
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 21:25 UTC
-
Fat cells fight brain cancer: new stem cell trial offers hope
Disease control Recruiting nowThis early-stage trial is testing whether stem cells from donated body fat can be safely injected into the brain during surgery to treat aggressive brain cancer that has returned. The study aims to find the safest dose and see if these cells can slow tumor growth and improve surv…
Matched conditions: RECURRENT ASTROCYTOMA, IDH-MUTANT, GRADE 4
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC